These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 35894206)

  • 1. Mapping the single-cell landscape of acral melanoma and analysis of the molecular regulatory network of the tumor microenvironments.
    He Z; Xin Z; Yang Q; Wang C; Li M; Rao W; Du Z; Bai J; Guo Z; Ruan X; Zhang Z; Fang X; Zhao H
    Elife; 2022 Jul; 11():. PubMed ID: 35894206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
    Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.
    Gui J; Guo Z; Wu D
    J Transl Med; 2022 Aug; 20(1):367. PubMed ID: 35974375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy Options for Acral Melanoma, A fast-growing but Neglected Malignancy.
    Gajón JA; Juarez-Flores A; De León Rodríguez SG; Aguilar Flores C; Mantilla A; Fuentes-Pananá EM; Bonifaz LC
    Arch Med Res; 2022 Dec; 53(8):794-806. PubMed ID: 36460547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acral melanoma: new insights into the immune and genomic landscape.
    Carvalho LAD; Aguiar FC; Smalley KSM; Possik PA
    Neoplasia; 2023 Dec; 46():100947. PubMed ID: 37913653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy.
    Li J; Smalley I; Chen Z; Wu JY; Phadke MS; Teer JK; Nguyen T; Karreth FA; Koomen JM; Sarnaik AA; Zager JS; Khushalani NI; Tarhini AA; Sondak VK; Rodriguez PC; Messina JL; Chen YA; Smalley KSM
    Clin Cancer Res; 2022 May; 28(10):2131-2146. PubMed ID: 35247927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a CD8+ T cells-related prognostic risk model for acral melanoma based on single-cell and bulk RNA sequencing.
    Wang W; Liu P; Ma J; Li J; Leng L
    Skin Res Technol; 2024 Aug; 30(8):e13900. PubMed ID: 39093712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial transcriptomic analysis of amelanotic acral melanoma versus pigmented acral melanoma reveals distinct molecular determinants.
    Choi ME; Choi EJ; Lee JH; Won CH; Chang SE; Lee MW; Lee WJ
    Br J Dermatol; 2024 Sep; 191(4):580-591. PubMed ID: 38815138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
    Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
    J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced Acral Melanoma Therapies: Current Status and Future Directions.
    Zhang Y; Lan S; Wu D
    Curr Treat Options Oncol; 2022 Oct; 23(10):1405-1427. PubMed ID: 36125617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
    Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
    Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More than just acral melanoma: the controversies of defining the disease.
    Bernardes SS; Ferreira I; Elder DE; Nobre AB; Martínez-Said H; Adams DJ; Robles-Espinoza CD; Possik PA
    J Pathol Clin Res; 2021 Nov; 7(6):531-541. PubMed ID: 34213090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
    Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham M; Lucas PC; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
    bioRxiv; 2023 Aug; ():. PubMed ID: 37662409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell RNA sequencing unveils tumor heterogeneity and immune microenvironment between subungual and plantar melanoma.
    Wang P; Ma Y; Zhao Y; Li Y; Tang C; Wang S; Jin S; Wang J; Zhu M; Xie B; Wang P
    Sci Rep; 2024 Mar; 14(1):7039. PubMed ID: 38528036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Narrative Review of the Evolution of Diagnostic Techniques and Treatment Strategies for Acral Lentiginous Melanoma.
    Choi ME; Choi EJ; Jung JM; Lee WJ; Jo YS; Won CH
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of single cell and bulk RNA sequencing reveals the heterogeneity of melanoma tumor microenvironment and predicts the response of immunotherapy.
    Zhang Y; Zhang C; He J; Lai G; Li W; Zeng H; Zhong X; Xie B
    Inflamm Res; 2024 Aug; 73(8):1393-1409. PubMed ID: 38896289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomic position determines oncogenic specificity in melanoma.
    Weiss JM; Hunter MV; Cruz NM; Baggiolini A; Tagore M; Ma Y; Misale S; Marasco M; Simon-Vermot T; Campbell NR; Newell F; Wilmott JS; Johansson PA; Thompson JF; Long GV; Pearson JV; Mann GJ; Scolyer RA; Waddell N; Montal ED; Huang TH; Jonsson P; Donoghue MTA; Harris CC; Taylor BS; Xu T; Chaligné R; Shliaha PV; Hendrickson R; Jungbluth AA; Lezcano C; Koche R; Studer L; Ariyan CE; Solit DB; Wolchok JD; Merghoub T; Rosen N; Hayward NK; White RM
    Nature; 2022 Apr; 604(7905):354-361. PubMed ID: 35355015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease.
    Basurto-Lozada P; Molina-Aguilar C; Castaneda-Garcia C; Vázquez-Cruz ME; Garcia-Salinas OI; Álvarez-Cano A; Martínez-Said H; Roldán-Marín R; Adams DJ; Possik PA; Robles-Espinoza CD
    Pigment Cell Melanoma Res; 2021 Jan; 34(1):59-71. PubMed ID: 32330367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
    Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
    Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain microenvironment-driven resistance to immune and targeted therapies in acral melanoma.
    Lee RJ; Khandelwal G; Baenke F; Cannistraci A; Macleod K; Mundra P; Ashton G; Mandal A; Viros A; Gremel G; Galvani E; Smith M; Carragher N; Dhomen N; Miller C; Lorigan P; Marais R
    ESMO Open; 2020 Aug; 5(4):. PubMed ID: 32817058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.